Gynecological follow-up of women undergoing hematopoietic stem cell transplantation (SFGM-TC and the French Society of Gynecology)

Gynecological follow-up of women who have undergone hematopoietic stem cell transplantation (HSCT) is complex, as it has multiple issues: fertility preservation; management of premature ovarian insufficiency or early menopause; infectious risk, particularly related to human papillomavirus; hemorrhagic risk during aplasia; screening for specific complications such as graft-versus-host disease (GVHD, only in the setting of allogeneic transplantation) or radiation-induced breast cancer; sexual and emotional health, etc. Clinical practices vary widely and remain heterogeneous among hospitals. The aim of this article is to provide a synthesis of the main gynecological issues and to propose French clinical practice recommendations in order to harmonize, systematize, and structure the gynecological follow-up of women undergoing HSCT.

Published by Bulletin du cancer, 2026. The guideline itself is at the source linked here.

doi.org/10.1016/j.bulcan.2026.03.009